# Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol

> **NCT00480883** · NA · COMPLETED · sponsor: **Combined Military Hospital, Pakistan** · enrollment: 400 (estimated)

## Conditions studied

- Leishmaniasis, Cutaneous

## Interventions

- **DRUG:** meglumine antimoniate, allopurinol
- **DRUG:** meglumine antimoniate
- **DRUG:** meglumine antimoniate, allopurinol

## Key facts

- **NCT ID:** NCT00480883
- **Lead sponsor:** Combined Military Hospital, Pakistan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2010-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00480883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00480883, "Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00480883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*